Premium
Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease
Author(s) -
Roblin X.,
Paul S.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13238
Subject(s) - adalimumab , medicine , infliximab , faecal calprotectin , ulcerative colitis , inflammatory bowel disease , gastroenterology , calprotectin , therapeutic drug monitoring , crohn's disease , regimen , vedolizumab , colitis , disease , immunology , pharmacokinetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom